Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Dapavo

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Dermatology Reports|March 6, 2025
Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasisPaolo Dapavo, Matteo Megna, Marina Talamonti
Case Reports in Dermatology|October 31, 2019
Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent TuberculosisSimone Ribero, Matteo Licciardello, Pietro Quaglino, et al.
Dermatologic Therapy|June 5, 2020
Pression-induced facial ulcers by prone position for COVID-19 mechanical ventilationAlice Ramondetta, Simone Ribero, Sonia Costi, et al.
Acta Dermato-Venereologica|August 16, 2022
Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case SeriesFederica Repetto, Lorenza Burzi, Simone Ribero, et al.
Expert Opinion on Biological Therapy|August 9, 2023
Reduced doses of biological therapies in psoriasis: a new potentially "sustainable" frontier of psoriasis treatmentSimone Ribero, Michela Ortoncelli, Luca Mastorino, et al.
Dermatologic Therapy|May 25, 2020
Moderate-to-severe hidradenitis suppurativa under systemic therapy during the COVID-19 outbreakGiulia Rozzo, Alice Ramondetta, Maria Teresa Fierro, et al.
Journal of the American Academy of Dermatology|July 31, 2016
The infliximab biosimilar in the treatment of moderate to severe plaque psoriasisPaolo Dapavo, Igor Vujic, Maria Teresa Fierro, et al.
European Journal of Dermatology : EJD|January 19, 2007
Infantile erythema elevatum diutinum: report of a vesiculo-bullous caseCarlo Tomasini, Zelda Seia, Paolo Dapavo, et al.
Journal of Clinical Medicine|December 9, 2023
Aging Impact in Response to Different Classes of Biological Treatment in Psoriatic Patients: A Real-Life Observational StudyFrancois Rosset, Luca Mastorino, Paolo Dapavo, et al.
Dermatologic Therapy|March 22, 2022
Persistent eruptive lentiginosis in a psoriatic patient after 4-year effective treatment with ustekinumabMichele Parietti, Lorenza Burzi, Simone Ribero, et al.
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Dermatology Reports|March 6, 2025
Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasisPaolo Dapavo, Matteo Megna, Marina Talamonti
Case Reports in Dermatology|October 31, 2019
Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent TuberculosisSimone Ribero, Matteo Licciardello, Pietro Quaglino, et al.
Dermatologic Therapy|June 5, 2020
Pression-induced facial ulcers by prone position for COVID-19 mechanical ventilationAlice Ramondetta, Simone Ribero, Sonia Costi, et al.
Acta Dermato-Venereologica|August 16, 2022
Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case SeriesFederica Repetto, Lorenza Burzi, Simone Ribero, et al.
Expert Opinion on Biological Therapy|August 9, 2023
Reduced doses of biological therapies in psoriasis: a new potentially "sustainable" frontier of psoriasis treatmentSimone Ribero, Michela Ortoncelli, Luca Mastorino, et al.
Dermatologic Therapy|May 25, 2020
Moderate-to-severe hidradenitis suppurativa under systemic therapy during the COVID-19 outbreakGiulia Rozzo, Alice Ramondetta, Maria Teresa Fierro, et al.
Journal of the American Academy of Dermatology|July 31, 2016
The infliximab biosimilar in the treatment of moderate to severe plaque psoriasisPaolo Dapavo, Igor Vujic, Maria Teresa Fierro, et al.
European Journal of Dermatology : EJD|January 19, 2007
Infantile erythema elevatum diutinum: report of a vesiculo-bullous caseCarlo Tomasini, Zelda Seia, Paolo Dapavo, et al.
Journal of Clinical Medicine|December 9, 2023
Aging Impact in Response to Different Classes of Biological Treatment in Psoriatic Patients: A Real-Life Observational StudyFrancois Rosset, Luca Mastorino, Paolo Dapavo, et al.
Dermatologic Therapy|March 22, 2022
Persistent eruptive lentiginosis in a psoriatic patient after 4-year effective treatment with ustekinumabMichele Parietti, Lorenza Burzi, Simone Ribero, et al.
Pageof 14